Table 1: Baseline demographic and characteristics of the 62 patients enrolled in this study.
|
NBP |
IH |
p-value |
Patient n (%) |
53 (85) |
9 (15) |
|
Gender n (%) |
Men |
32 (60) |
5 (56) |
0.999 |
Women |
21 (40) |
4 (44) |
Age (y) |
74[63-80] |
75[61-80] |
0.734 |
Maintenance dialysis duration (y) |
8.05 ± 4.07 |
8.33 ± 3.33 |
0.885 |
Session duration (Hours) |
4.2 [4, 5] |
4.1[4-4.4] |
0.063 |
Antihypertensive medications n (%) |
ARB |
14 (26) |
2 (22) |
0.999 |
β blockers |
34 (64) |
7 (77) |
0.705 |
CCB |
34 (64) |
9 (100) |
0.464 |
α 1 blockers |
15 (28) |
1 (11) |
0.670 |
α and β blocking agents |
2 (3) |
0 (0) |
0.999 |
Diuretics |
19 (35) |
2 (22) |
0.705 |
Vasodilators |
12 (22) |
0 (0) |
0.185 |
ARB + CCB |
11 (20) |
1 (11) |
0.675 |
Nephropathy causes n (%) |
Hypertension |
20 (38) |
3 (33) |
0.999 |
Diabetes mellitus |
15 (28) |
1 (11) |
0.425 |
Glomerulonephritis |
7 (13) |
4 (45) |
0.044 |
Polycystic disease |
4 (8) |
0 (0) |
0.999 |
Chronic tubulo-interstitial nephritis |
4 (8) |
0 (0) |
0.999 |
Unknown |
3 (5) |
1 (11) |
0.475 |
ARB: angiotensin II receptor blocker; CCB: calcium channel blockers; n: number of patients in each group, y: years. Data are represented as mean ± SD or as median with its interquartile range (IQR = Q1- Q3). The T-test, Mann-Whitney U test and Fisher exact test were used as appropriate.